companydata.dkcompanydata.dk

Incyte Biosciences Denmark ApS: Financial statements 2023

CVR: 35818790

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 6,283,403 and a net result of DKK 374,584 compared with DKK 277,949 the year before. That is an increase of 13.1% compared with the year before. Equity in the 2023 report amounted to DKK 1,598,472. The solvency ratio was 34.7%. The company had 4 employees in the financial year.

Gross Profit
DKK 6,283,403
Profit/Loss
DKK 374,584
Equity
DKK 1,598,472
Total Assets
DKK 4,603,464
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-6.3M375K1.6M4
2022-5.6M278K1.2M4
2021-5.3M269K946K4
2020-5.4M150K677K3
2019-4.8M286K527K3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Incyte Biosciences Denmark ApS: The 2022 annual report is outMay 17, 2023

Incyte Biosciences Denmark ApS has published its annual report for 2022. Gross profit came to DKK 5,556,640, and the net result was DKK 277,949.

About Incyte Biosciences Denmark ApS

Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.

Source: annual report 2025, Danish Business Authority